Skip to main content
. 2017 Jul 14;23(26):4831–4838. doi: 10.3748/wjg.v23.i26.4831

Table 5.

5-year cancer-specific survival in percent (number of cases) vs intensity of staining in the tumour bulk, invasive front, and lymph node metastases n (%)

Intensity of staining Whole colon P value1 Proximal colon P valu1 Distal colon and rectum P value1
TLR2 Tumour bulk Weak 14 (63.6) 0.43 4 (66.7) 0.65 9 (60.0) 0.33
Strong 71 (74.7) 29 (74.4) 42 (75.0)
Invasive front Weak 14 (73.7) > 0.9 6 (66.7) 0.68 8 (80.0) 0.71
Strong 70 (72.2) 27 (75.0) 42 (70.0)
Lymph node Weak 9 (50.0) 0.55 3 (37.5) > 0.9 6 (60.0) 0.26
Strong 10 (40.0) 3 (42.9) 6 (35.3)
TLR4 Tumour bulk Weak 25 (65.8) 0.27 7 (63.6) 0.45 18 (66.7) 0.59
Strong 60 (75.9) 26 (76.5) 33 (75.0)
Invasive front Weak 17 (63.0) 0.33 5 (45.5) 0.044 12 (75.0) > 0.9
Strong 67 (75.3) 28 (82.4) 38 (70.4)
Lymph node Weak 2 (25.0) 0.27 0 (0.0) 0.23 2 (40.0) > 0.9
Strong 17 (48.6) 6 (50.0) 10 (45.5)
1

χ2 test/Fisher’s exact test. N values vary due to missing samples; One case with multiple tumours excluded from location-based analysis; Weak intensity < 2 and strong intensity ≥ 2.